Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus
about
Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosisArterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeysEndothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor.The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivityIncreased atherosclerosis in mice with increased vascular biglycan content.Molecular mechanisms of diabetic cardiovascular disease.Hyperglycemia impairs atherosclerosis regression in mice.High glucose attenuates shear-induced changes in endothelial hydraulic conductivity by degrading the glycocalyxArterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp ratVascular hypertrophy in experimental diabetes. Role of advanced glycation end products.Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin.Reduced glomerular size- and charge-selectivity in clinically healthy individuals with microalbuminuria.Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans.Reduced expression of perlecan in the aorta of secondary hyperparathyroidism model rats with medial calcification.Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetes.Structural Determinants in the C-terminal Domain of Apolipoprotein E Mediating Binding to the Protein Core of Human Aortic Biglycan
P2860
Q24676643-77A7ADF7-1404-4B0C-9DEC-DCD0BC73BC4EQ24792393-EB5F1CD1-50A8-4EB3-B9D9-9C3FC2EF1537Q24816272-B46C6960-6184-4E43-A657-3FAB805B1A21Q28140341-5EEE6AD5-3DF3-458F-8EB1-78B27E5851A2Q33745040-6DDE190E-F9DF-4A76-9CE6-CC0161F5C284Q34989681-43722C73-9140-41F4-ADC4-27A18D7075C7Q35013804-5C39DE20-05FF-44B7-89BF-9B6B49F65DE6Q35048132-7320E4DE-106F-461A-849D-06FB965E6B1BQ36522670-864E973E-3903-4ED1-8B57-738CAF6392F1Q37364608-1D3F73DA-3337-4685-B626-F650AB8339A4Q37877470-0A806248-3CFF-409C-BAFE-72BE19763BD6Q39572643-33D05397-E0F2-4D41-A3A8-4672DD76A063Q42125176-5614F463-7280-4151-8DF9-AF5006AED36BQ47349977-48C11CFF-6022-45EA-B34C-DA0DC3E35DEEQ47693851-63235702-15EB-4682-AC7F-BAFC3862FED8Q51384216-DFC40809-B943-4586-8A80-B922FA22664BQ53338421-84A7EC99-900C-4147-AEDC-5A16AF9423B2Q53558779-5EAA78C1-3CDF-4BEA-A09C-74729B8B2BF2Q58924655-3BAD723A-FA48-4988-873E-C97FBDDE64B9
P2860
Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@ast
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@en
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@nl
type
label
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@ast
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@en
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@nl
prefLabel
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@ast
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@en
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@nl
P2093
P356
P1433
P1476
Distribution of glycosaminogly ...... clerosis and diabetes mellitus
@en
P2093
P2888
P304
P356
10.1007/BF00400234
P407
P577
1993-04-01T00:00:00Z
P6179
1040624077